1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Brain Metastasis Global Clinical Trials Review, H1, 2014

Brain Metastasis Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 111 pages

Brain Metastasis Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Brain Metastasis Global Clinical Trials Review, H1, 2014" provides data on the Brain Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Brain Metastasis Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Brain Metastasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Brain Metastasis to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Brain Metastasis to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Brain Metastasis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Brain Metastasis Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Brain Metastasis 35
Nov 12, 2013: Study Demonstrates biOasis Technologies' Conjugate of Metastatic Cancer Drug, Herceptin, Penetrates Blood-Tumor Barrier 10 Times Greater Than Herceptin Alone 35
Apr 09, 2013: biOasis Provides Update On BT2111-Herceptin Program 35
Dec 03, 2012: Geron Discontinues Development Of Brain Cancer Drug Candidate GRN1005 36
Mar 15, 2012: Novelos Announces Enrollment Of First Patient In Brain Cancer Trial Of i-124-clr1404 36
Dec 22, 2011: Geron Initiates Phase II Trial Of GRN1005 In Brain Metastases Arising From Lung Cancer 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
F. Hoffmann-La Roche Ltd. 40
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 40
Merck and Co., Inc. 42
Clinical Trial Overview of Merck and Co., Inc. 42
Bayer AG 43
Clinical Trial Overview of Bayer AG 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
AngioChem Inc. 46
Clinical Trial Overview of AngioChem Inc. 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Pharmacyclics, Inc. 48
Clinical Trial Overview of Pharmacyclics, Inc. 48
AstraZeneca PLC 49
Clinical Trial Overview of AstraZeneca PLC 49
Clinical Trial Overview of Top Institutes / Government 50
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
The University of Texas M. D. Anderson Cancer Center 52
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 52
Duke University 53
Clinical Trial Overview of Duke University 53
Radiation Therapy Oncology Group 54
Clinical Trial Overview of Radiation Therapy Oncology Group 54
Memorial Sloan Kettering Cancer Center 55
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 55
University Health Network 56
Clinical Trial Overview of University Health Network 56
Thomas Jefferson University 57
Clinical Trial Overview of Thomas Jefferson University 57
Case Comprehensive Cancer Center 58
Clinical Trial Overview of Case Comprehensive Cancer Center 58
European Organization for Research and Treatment of Cancer 59
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 59
Five Key Clinical Profiles 60
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 111

List of Tables
Brain Metastasis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Brain Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Brain Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Brain Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Brain Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Brain Metastasis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Brain Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Brain Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Brain Metastasis to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Brain Metastasis to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Brain Metastasis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Brain Metastasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Brain Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Brain Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Brain Metastasis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Brain Metastasis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Brain Metastasis Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Brain Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Brain Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Brain Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Brain Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Brain Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 40
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 42
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 43
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 44
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 45
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AngioChem Inc., 2014* 46
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 47
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2014* 48
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 49
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 50
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 52
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 53
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 54
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 55
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 56
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014* 57
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 58
Brain Metastasis Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 59

List of Figures
Brain Metastasis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Brain Metastasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Brain Metastasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Brain Metastasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Brain Metastasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Brain Metastasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Brain Metastasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Brain Metastasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Brain Metastasis to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Brain Metastasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Brain Metastasis to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Brain Metastasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Brain Metastasis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Brain Metastasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Brain Metastasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Brain Metastasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Brain Metastasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Brain Metastasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Brain Metastasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Brain Metastasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 109

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.